Publications

Weightloss

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Read More…

COVID-19 treatment

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

Read More…

Monocolonal Antibody treatment

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Read More…

Atopic Dermatitis

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Read More…

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Read More…

Pediatric COVID-19 Vaccine

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Read More…

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

Read More…